C.A. Navascués

Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis

Rosario Velázquez, Manuel Rodríguez, C.A. Navascués et al. · Hepatology · 2003 · 438 citations · Full text

Medicine, Internal Medicine, Oncology +17

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

Andrea De Gottardi, Jonel Trebicka, Christoph Klinger et al. · Liver International · 2016 · 229 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

José Luís Calleja, Javier Crespo, Diego Rincón et al. · Journal of Hepatology · 2017 · 188 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups

Maria-Luisa González-Diéguez, Valle Cadahía, Marı́a Varela et al. · Clinical Gastroenterology and Hepatology · 2012 · 148 citations

Medicine, Oncology, Cancer Epidemiology +16

Epidemiology of hepatitis D virus infection: changes in the last 14 years.

C.A. Navascués, Manuel Rodríguez, N.G. Sotorrío et al. · PubMed · 1995 · 85 citations

Medicine, Infectious Diseases, Clinical Epidemiology +11